Although GLP-1 drugs have existed for at least a decade, they did not truly hit the headlines until this year
However, the emergence of viral variants, particularly Omicron strains with more than 30 mutations in the spike protein, has diminished the efficacy of several marketed antibodies, driving the development of therapeutics with broader neutralizing capabilities 47
They honed in on six RCTs of more than 3,200 individuals that followed patients for up to 52 weeks after they stopped taking weight-loss drugs then developed a model to predict what would happen beyond that
[6] There is no official evidence that tirzepatide causes physical dependence or withdrawal symptoms in the traditional sense, but the underlying metabolic conditions will reassert themselves without ongoing pharmacological support
However, some people may notice: decreased hunger feeling full sooner than usual mild fatigue or dizziness if calorie intake drops too quickly Monitoring nutrition and energy levels during treatment is important